• Nenhum resultado encontrado

Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China.

N/A
N/A
Protected

Academic year: 2017

Share "Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China."

Copied!
11
0
0

Texto

Loading

Imagem

Table 1. Demographic/clinical characteristics and prevalence of anti-TB drug resistance of study populations.
Fig 1. Overall drug resistance (%) in TB patients with and without COPD. (INH, isoniazid; RFP, rifampicin; MDR, multidrug-resistant; EMB, ethambutol; SM, streptomycin; KM, kanamycin; CPM, capreomycin; OFLX, ofloxacin; MDR+OFLX, MDR plus resistance to oflox
Table 2. Univariable and multivariable analysis of risk factors for MDR-TB in patients with COPD.
Fig 2. ROC curve to assess the discriminatory ability of the model predicting MDR-TB in patients with COPD.

Referências

Documentos relacionados

A study conducted in South Africa showed that the treatment of one patient with XDR-TB costs US$ 26,392, which is four times higher than the treatment of one patient with MDR-TB

Recommendations for the Evaluation and Treatment of Muscle Dysfunction in Patients With Chronic Obstructive Pulmonary Disease. Pulmonary rehabilitation in patients

Interleukin-6 (IL- 6) is an important cytokine whose serum levels are commonly high in active pulmonary tuberculosis (TB). IL-6 screening in contacts of patients with TB may be

The MWT is an independent survivor predictor in patients with severe chronic obstructive pulmo- nary disease COPD , heart failure and pulmonary hypertension. )n these diseases

Esta construção possibilita a criação de identidades sociais, que “marcam de forma visível e perpetuada a existência do grupo, da classe ou da comunidade” (idem). Investigando

As actividades exteriores dos dirigentes das explorações agrícolas constituem, por regra, a actividade principal, sobretudo para o caso do sector secundário em que a actividade

The current study aimed to estimate the incidence of MDR-TB in the city of Santos, describe the profile of TB drug resistance in risk groups and examine the adherence to

Resultados: O presente estudo demonstrou que o antagonista do MIF (p425) diminuiu significativamente proteinúria, excreção urinária de GAGs , relação proteína/creatinina na